Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 3005 | 40.84 |
09:33 ET | 4410 | 41.57 |
09:35 ET | 1100 | 41.49 |
09:37 ET | 2382 | 41.56 |
09:39 ET | 2942 | 42 |
09:42 ET | 9800 | 41.7175 |
09:44 ET | 1896 | 41.34 |
09:46 ET | 300 | 41.34 |
09:48 ET | 1399 | 41.5801 |
09:50 ET | 2620 | 41.45 |
09:51 ET | 300 | 41.45 |
09:53 ET | 4943 | 41.425 |
09:55 ET | 1600 | 41.425 |
09:57 ET | 5053 | 41.48 |
10:00 ET | 300 | 41.425 |
10:02 ET | 2644 | 41.775 |
10:04 ET | 100 | 41.75 |
10:06 ET | 100 | 41.74 |
10:08 ET | 1543 | 41.725 |
10:09 ET | 1300 | 41.615 |
10:11 ET | 2242 | 41.63 |
10:13 ET | 16301 | 41.05 |
10:15 ET | 304 | 40.97 |
10:18 ET | 1100 | 41.115 |
10:20 ET | 695 | 41.11 |
10:22 ET | 500 | 40.97 |
10:24 ET | 7209 | 41.03 |
10:26 ET | 32658 | 40.84 |
10:27 ET | 2786 | 40.87 |
10:29 ET | 2000 | 40.85 |
10:31 ET | 6597 | 40.63 |
10:33 ET | 3773 | 40.51 |
10:36 ET | 2300 | 40.5 |
10:38 ET | 4066 | 40.73 |
10:40 ET | 1500 | 40.67 |
10:42 ET | 1820 | 40.57 |
10:44 ET | 1330 | 40.7 |
10:45 ET | 1119 | 40.61 |
10:47 ET | 6097 | 41.12 |
10:49 ET | 3300 | 41.1 |
10:51 ET | 400 | 41.07 |
10:54 ET | 6182 | 40.945 |
10:56 ET | 3230 | 40.76 |
10:58 ET | 870 | 40.63 |
11:00 ET | 800 | 40.59 |
11:02 ET | 800 | 40.665 |
11:03 ET | 600 | 40.6 |
11:05 ET | 200 | 40.6 |
11:07 ET | 1500 | 40.78 |
11:09 ET | 857 | 40.72 |
11:14 ET | 1297 | 40.77 |
11:16 ET | 5413 | 40.9 |
11:18 ET | 15544 | 40.845 |
11:20 ET | 7285 | 40.82 |
11:21 ET | 3860 | 40.82 |
11:23 ET | 500 | 40.88 |
11:25 ET | 2578 | 40.865 |
11:27 ET | 7041 | 40.62 |
11:30 ET | 1888 | 40.655 |
11:32 ET | 3727 | 40.655 |
11:34 ET | 700 | 40.4 |
11:36 ET | 1171 | 40.47 |
11:38 ET | 300 | 40.47 |
11:39 ET | 400 | 40.41 |
11:41 ET | 702 | 40.49 |
11:43 ET | 1942 | 40.3 |
11:45 ET | 2576 | 40.34 |
11:48 ET | 200 | 40.41 |
11:50 ET | 100 | 40.385 |
11:52 ET | 300 | 40.33 |
11:54 ET | 300 | 40.405 |
11:56 ET | 300 | 40.43 |
11:57 ET | 1600 | 40.52 |
11:59 ET | 400 | 40.525 |
12:01 ET | 800 | 40.52 |
12:03 ET | 500 | 40.55 |
12:06 ET | 1600 | 40.44 |
12:08 ET | 1959 | 40.22 |
12:10 ET | 300 | 40.32 |
12:12 ET | 1300 | 40.3 |
12:14 ET | 1468 | 40.295 |
12:17 ET | 300 | 40.28 |
12:19 ET | 5892 | 39.85 |
12:21 ET | 1800 | 39.9 |
12:24 ET | 1100 | 39.885 |
12:26 ET | 300 | 39.88 |
12:28 ET | 700 | 39.88 |
12:30 ET | 7669 | 39.6 |
12:32 ET | 1335 | 39.5295 |
12:33 ET | 500 | 39.53 |
12:35 ET | 1343 | 39.71 |
12:37 ET | 2105 | 39.66 |
12:39 ET | 1800 | 39.78 |
12:42 ET | 1600 | 39.85 |
12:44 ET | 4140 | 39.72 |
12:46 ET | 400 | 39.7 |
12:48 ET | 600 | 39.61 |
12:50 ET | 1700 | 39.69 |
12:51 ET | 900 | 39.72 |
12:53 ET | 800 | 39.69 |
12:55 ET | 937 | 39.7 |
12:57 ET | 15644 | 40.1 |
01:00 ET | 1324 | 40.01 |
01:02 ET | 300 | 40.0914 |
01:04 ET | 700 | 40.07 |
01:06 ET | 800 | 40.145 |
01:08 ET | 4823 | 40.21 |
01:09 ET | 2944 | 40 |
01:11 ET | 4191 | 39.99 |
01:13 ET | 3460 | 39.84 |
01:15 ET | 5069 | 40.0899 |
01:18 ET | 640 | 39.95 |
01:24 ET | 100 | 39.96 |
01:26 ET | 400 | 39.95 |
01:27 ET | 100 | 39.95 |
01:29 ET | 200 | 40.02 |
01:31 ET | 308 | 39.95 |
01:33 ET | 3152 | 40.025 |
01:36 ET | 640 | 39.99 |
01:38 ET | 6980 | 40.07 |
01:40 ET | 283 | 40.13 |
01:42 ET | 1687 | 40.16 |
01:44 ET | 429 | 40.17 |
01:45 ET | 700 | 40.21 |
01:47 ET | 400 | 40.19 |
01:49 ET | 2000 | 40.14 |
01:51 ET | 995 | 40.11 |
01:56 ET | 300 | 40.13 |
01:58 ET | 3007 | 40.055 |
02:00 ET | 529 | 40.055 |
02:02 ET | 2000 | 39.9 |
02:03 ET | 100 | 39.82 |
02:05 ET | 200 | 39.72 |
02:07 ET | 100 | 39.67 |
02:09 ET | 450 | 39.76 |
02:12 ET | 500 | 39.76 |
02:14 ET | 4325 | 39.79 |
02:16 ET | 5215 | 39.66 |
02:18 ET | 4070 | 39.86 |
02:20 ET | 792 | 39.865 |
02:21 ET | 425 | 39.89 |
02:23 ET | 1652 | 39.82 |
02:25 ET | 350 | 39.89 |
02:27 ET | 100 | 39.78 |
02:30 ET | 1289 | 39.6702 |
02:32 ET | 915 | 39.65 |
02:34 ET | 712 | 39.725 |
02:36 ET | 2678 | 39.505 |
02:38 ET | 4977 | 39.63 |
02:39 ET | 2530 | 39.58 |
02:41 ET | 300 | 39.58 |
02:43 ET | 8250 | 39.595 |
02:45 ET | 7663 | 39.595 |
02:48 ET | 800 | 39.6 |
02:50 ET | 1700 | 39.76 |
02:52 ET | 100 | 39.72 |
02:54 ET | 100 | 39.77 |
02:56 ET | 400 | 39.79 |
02:57 ET | 2693 | 39.56 |
02:59 ET | 400 | 39.6 |
03:01 ET | 500 | 39.571 |
03:03 ET | 300 | 39.58 |
03:06 ET | 1295 | 39.74 |
03:08 ET | 1250 | 39.78 |
03:10 ET | 300 | 39.85 |
03:12 ET | 1570 | 39.87 |
03:14 ET | 400 | 39.91 |
03:15 ET | 3348 | 39.935 |
03:17 ET | 7992 | 40.14 |
03:19 ET | 21549 | 40.33 |
03:21 ET | 1366 | 40.255 |
03:24 ET | 850 | 40.275 |
03:26 ET | 1409 | 40.295 |
03:28 ET | 9840 | 40.12 |
03:30 ET | 1200 | 40.12 |
03:32 ET | 2510 | 40.07 |
03:33 ET | 3449 | 39.975 |
03:35 ET | 2551 | 39.965 |
03:37 ET | 3718 | 40.085 |
03:39 ET | 1510 | 40.05 |
03:42 ET | 1713 | 40.14 |
03:44 ET | 3115 | 40.14 |
03:46 ET | 2970 | 40.13 |
03:48 ET | 7052 | 40.095 |
03:50 ET | 3804 | 40.135 |
03:51 ET | 7366 | 40.105 |
03:53 ET | 14649 | 39.9 |
03:55 ET | 12000 | 39.945 |
03:57 ET | 19949 | 39.755 |
04:00 ET | 122898 | 39.74 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 2.4B | -17.8x | --- |
Longboard Pharmaceuticals Inc | 2.3B | -27.5x | --- |
Vera Therapeutics Inc | 2.4B | -20.5x | --- |
CG Oncology Inc | 2.4B | -31.5x | --- |
Keros Therapeutics Inc | 2.2B | -11.7x | --- |
Akero Therapeutics Inc | 2.2B | -9.4x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.24 |
Book Value | $9.76 |
P/E Ratio | -17.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.